University of Hertfordshire

From the same journal

By the same authors

Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era

Research output: Contribution to journal › Article › peer-review

Standard

Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era. / Ng, Kenrick; Vinnakota, Krishna; Sharma, Anand; Cresswell, Joanne; Kelly, John; Dasgupta, Prokar; Vasdev, Nikhil.

In: Nature Reviews Urology, 17.12.2020.

Research output: Contribution to journal › Article › peer-review

Harvard

Ng, K, Vinnakota, K, Sharma, A, Cresswell, J, Kelly, J, Dasgupta, P & Vasdev, N 2020, 'Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era', Nature Reviews Urology. https://doi.org/10.1038/s41585-020-00419-z

APA

Ng, K., Vinnakota, K., Sharma, A., Cresswell, J., Kelly, J., Dasgupta, P., & Vasdev, N. (2020). Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era. Nature Reviews Urology. https://doi.org/10.1038/s41585-020-00419-z

Vancouver

Ng K, Vinnakota K, Sharma A, Cresswell J, Kelly J, Dasgupta P et al. Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era. Nature Reviews Urology. 2020 Dec 17. https://doi.org/10.1038/s41585-020-00419-z

Author

Ng, Kenrick ; Vinnakota, Krishna ; Sharma, Anand ; Cresswell, Joanne ; Kelly, John ; Dasgupta, Prokar ; Vasdev, Nikhil. / Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era. In: Nature Reviews Urology. 2020.

Bibtex

@article{07ffb1c18a6d4b1dace5d71fb689248a,
title = "Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era",
abstract = "The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.",
author = "Kenrick Ng and Krishna Vinnakota and Anand Sharma and Joanne Cresswell and John Kelly and Prokar Dasgupta and Nikhil Vasdev",
note = "{\textcopyright} 2020, Springer Nature Limited. This is the accepted manuscript version of an article which has been published in final form at https://doi.org/10.1038/s41585-020-00419-z",
year = "2020",
month = dec,
day = "17",
doi = "10.1038/s41585-020-00419-z",
language = "English",
journal = "Nature Reviews Urology",
issn = "1759-4812",
publisher = "Nature Publishing Group",

}

RIS

TY - JOUR

T1 - Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era

AU - Ng, Kenrick

AU - Vinnakota, Krishna

AU - Sharma, Anand

AU - Cresswell, Joanne

AU - Kelly, John

AU - Dasgupta, Prokar

AU - Vasdev, Nikhil

N1 - © 2020, Springer Nature Limited. This is the accepted manuscript version of an article which has been published in final form at https://doi.org/10.1038/s41585-020-00419-z

PY - 2020/12/17

Y1 - 2020/12/17

N2 - The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.

AB - The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.

U2 - 10.1038/s41585-020-00419-z

DO - 10.1038/s41585-020-00419-z

M3 - Article

JO - Nature Reviews Urology

JF - Nature Reviews Urology

SN - 1759-4812

ER -